Discussion
GLP-1 receptor agonists (GLP-1RAs), medications commonly used for diabetes and weight loss, may improve lung function in adults with cystic fibrosis-related diabetes (CFRD), according to a small, exploratory study from Australia. After one year of treatment, patients given a GLP-1RA in addition to insulin, the standard CFRD treatment, had significant…
